Long-term studies with ranitidine show that the drug molecule is broken down in the body into a substance called N-nitrosodimethylamine (NDMA). According to the World Health Organization, NDMA is considered a potent carcinogen. According to a number of studies, the use of ranitidine causes the accumulation of NDMA in quantities many times higher than is considered safe. Based on these findings, the popular drug was seized worldwide.
NDMA has been linked to cancers including esophageal cancer, bladder cancer, stomach cancer, kidney cancer, colon cancer, pancreatic cancer, liver cancer, and prostate cancer in patients under 65 years of age at diagnosis. If you or a loved one has used NDMA and has cancer, we encourage you to contact our team of empathetic lawyers today to explore your legal options.
We will always listen to your circumstances and give you our analysis of your case without any cost or further obligation. To access your free, no-obligation consultation, use the online chat feature or contact form on this site. One of our lawyers handling Zantac lawsuits for cancer will contact you to answer any of your questions.
Image Source: Google
Bladder cancer has a 5-year survival rate of 96% if detected before the disease spreads from the bladder. In cases where cancer has spread from the bladder, the survival rate is reduced to 5%. Symptoms of bladder cancer can include blood in the urine, frequent urination, painful urination, and low back pain.
Stomach cancer has a 5-year post-diagnosis survival rate of 69% if cancer remains localized in the stomach. When stomach cancer spreads to other parts of the body, the survival rate drops to 5%. Symptoms of stomach cancer include loss of appetite, heartburn, vomiting with blood, and dark stools.